|
Q3 FY2026
As of Sep 30, 2026
|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net of allowance for credit losses of $4,733 and $5,103 at September 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Inventory, net | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Office furniture and equipment | ||||||||||||||||||||
| Molds and tooling | ||||||||||||||||||||
| Property and equipment, gross | ||||||||||||||||||||
| Furniture and Fixtures | ||||||||||||||||||||
| Tools, Dies and Molds | ||||||||||||||||||||
| Leasehold Improvements | ||||||||||||||||||||
| Total property and equipment, gross | ||||||||||||||||||||
| Less accumulated depreciation and amortization | ||||||||||||||||||||
| Property and equipment, net | ||||||||||||||||||||
| Operating lease right-of-use assets, net | ||||||||||||||||||||
| Other long-term assets | ||||||||||||||||||||
| Deferred income tax assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders’ Equity | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accounts payable - Meisheng (related party) | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Reserve for sales returns and allowances | ||||||||||||||||||||
| Income taxes payable | ||||||||||||||||||||
| Short-term operating lease liabilities | ||||||||||||||||||||
| Short-term debt, net | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Long-term operating lease liabilities | ||||||||||||||||||||
| Accrued expenses – long term | ||||||||||||||||||||
| Debt, non-current portion, net of issuance costs and debt discounts | ||||||||||||||||||||
| Preferred stock derivative liability | ||||||||||||||||||||
| Accrued expenses, long-term | ||||||||||||||||||||
| Income taxes payable, long-term | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Preferred stock accrued dividends, $0.001 par value; 5,000,000 shares authorized; nil and 200,000 shares issued and outstanding at December 31, 2024 and 2023, respectively | ||||||||||||||||||||
| Stockholders’ Equity | ||||||||||||||||||||
| Common stock, $0.001 par value; 100,000,000 shares authorized; 11,467,105 and 11,342,981 shares issued and outstanding at September 30, 2026 and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Accumulated other comprehensive loss | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Non-controlling interests | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
